Profil
Mark A.
Young is the founder of CeNeS Pharmaceuticals, Inc. He previously worked as the Chairman of Enssolutions Group, Inc. from 2014 to 2018.
Ehemalige bekannte Positionen von Mark A. Young
| Unternehmen | Position | Ende |
|---|---|---|
| ENSSOLUTIONS GROUP INC. | Vorsitzender | 28.12.2018 |
CeNeS Pharmaceuticals, Inc.
 CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Enssolutions Group, Inc.
 Enssolutions Group, Inc. Chemicals: SpecialtyProcess Industries Enssolutions Group, Inc. engages in the manufacture, distribution, and application of organic liquid pine rosin emulsions. It also provides engineered environmental solutions for mine tailings control, process dust and erosion control, granular stabilization, road construction and maintenance, and stockpile sealing. It operates through the following segments: Canada, United States, and Corporate. The company was founded on February 8, 2007 and is headquartered in Beamsville, Canada. | Process Industries |
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Health Technology |
